SallyJYorkMD

Oncology • Nashville, TN

Hematologic Oncology, Thoracic Cancer

Associate Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. York is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. York's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Fax+1 615-936-0605
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 1999 - 2001
Duke University HospitalResidency, Internal Medicine, 1996 - 1999
Washington University in St. Louis School of MedicineClass of 1996

Certifications & Licensure

TN State Medical License 2012 - 2024
AL State Medical License 2020 - 2020
NC State Medical License 1997 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Completed
Phase 2
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer.
Eric M Lander, Xuanyi Li, Li-Ching Huang, Amanda S Cass, Wade T Iams, Emily A Skotte, Jennifer G Whisenant, Robert A Ramirez, Sally J York, Travis J Osterman, Jennifer...> ;Journal of the National Comprehensive Cancer Network. 2023 Oct 1
Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors.
Emily Pei-Ying Lin, Li-Ching Huang, Jennifer Whisenant, Sally York, Travis Osterman, Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leor...> ;ERJ Open Research. 2022 Oct 1
Resolution of Airway Lesions in Recurrent Respiratory Laryngeal Papillomatosis With Radiation Therapy.
Ankush P Ratwani, Sally J York, Fabien Maldonado, Evan C Osmundson, Otis B Rickman, Lentz, R. J., Robert J Lentz> ;Journal of Bronchology & Interventional Pulmonology. 2023 Jul 1
4 citations
Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC.
Jarrod T. Smith, Aneri B. Balar, Dhairya A. Lakhani, Christien Kluwe, Zhiguo Zhao, Prasad R. Kopparapu, Karinna Almodovar, Anel Muterspaugh, Yingjun Yan, Sally York, L...> ;JTO Clinical and Research Reports. 2021 Mar 1
7 citations
Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease
Wade T. Iams, Prasad R. Kopparapu, Yingjun Yan, Anel Muterspaugh, Zhiguo Zhao, Heidi Chen, Christopher G. Cann, Sally York, Leora Horn, Kristin K. Ancell, Kenneth Wyma...> ;JTO Clinical and Research Reports. 2020 Jun 1
4 citations
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An In...
Vipul Sheth, Vanessa E Kennedy, Hugues de Lavallade, Donal P. McLornan, Victoria T Potter, Brian G. Engelhardt, Bipin N. Savani, Wichai Chinratanalab, Stacey Goodman, ...> ;Frontiers in Oncology. 2019 Jul 10
85 citations
Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Karinna Almodovar, Wade T. Iams, Catherine B. Meador, Zhiguo Zhao, Sally York, Leora Horn, Yingjun Yan, Jennifer Hernandez, Heidi Chen, Yu Shyr, Lee P. Lim, Christophe...> ;Journal of Thoracic Oncology. 2018 Jan 1
80 citations
EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib
Jean-Nicolas Gallant, Jonathan H. Sheehan, Timothy M. Shaver, Mark Bailey, Doron Lipson, Raghu Chandramohan, Monica Red Brewer, Sally York, Mark G. Kris, Jennifer A. P...> ;Cancer Discovery. 2015 Nov 1
67 citations
Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts
Sally J. York, Paul Modrich> ;The Journal of Biological Chemistry. 2006 Aug 11
121 citations
Inositol Diphosphate Signaling Regulates Telomere Length
Sally J. York, Blaine N. Armbruster, Patricia W. Greenwell, Thomas D. Petes, John D. York> ;The Journal of Biological Chemistry. 2005 Feb 11
The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding.
York SJ, Arneson LS, Gregory WT, Dahms NM, Kornfeld S> ;J. Biol. Chem.. 1999-01-08
Join now to see all